These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36572715)

  • 21. Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: a longitudinal investigation using the National Alzheimer's Coordinating Center Uniform Data Set.
    Puzo C; Labriola C; Sugarman MA; Tripodis Y; Martin B; Palmisano JN; Steinberg EG; Stein TD; Kowall NW; McKee AC; Mez J; Killiany RJ; Stern RA; Alosco ML
    Alzheimers Res Ther; 2019 Jul; 11(1):64. PubMed ID: 31351489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cortical β-amyloid burden, neuropsychiatric symptoms, and cognitive status: the Mayo Clinic Study of Aging.
    Krell-Roesch J; Vassilaki M; Mielke MM; Kremers WK; Lowe VJ; Vemuri P; Machulda MM; Christianson TJ; Syrjanen JA; Stokin GB; Butler LM; Traber M; Jack CR; Knopman DS; Roberts RO; Petersen RC; Geda YE
    Transl Psychiatry; 2019 Mar; 9(1):123. PubMed ID: 30923322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of neuropsychiatric symptoms in mild cognitive impairment and Alzheimer's disease, and its relationship with cognitive impairment.
    M FM; Molano A; Castro J; Zarranz JJ
    Curr Alzheimer Res; 2010 Sep; 7(6):517-26. PubMed ID: 20455862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuropsychiatric predictors of progression from amnestic-mild cognitive impairment to Alzheimer's disease: the role of depression and apathy.
    Palmer K; Di Iulio F; Varsi AE; Gianni W; Sancesario G; Caltagirone C; Spalletta G
    J Alzheimers Dis; 2010; 20(1):175-83. PubMed ID: 20164594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diffusion tensor imaging of neuropsychiatric symptoms in mild cognitive impairment and Alzheimer's dementia.
    Tighe SK; Oishi K; Mori S; Smith GS; Albert M; Lyketsos CG; Mielke MM
    J Neuropsychiatry Clin Neurosci; 2012; 24(4):484-8. PubMed ID: 23224456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Affective Neuropsychiatric Symptoms as Early Signs of Dementia Risk in Older Adults.
    Jang JY; Ho JK; Blanken AE; Dutt S; Nation DA;
    J Alzheimers Dis; 2020; 77(3):1195-1207. PubMed ID: 32925031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuropsychiatric symptoms, APOE ε4, and the risk of incident dementia: a population-based study.
    Pink A; Stokin GB; Bartley MM; Roberts RO; Sochor O; Machulda MM; Krell-Roesch J; Knopman DS; Acosta JI; Christianson TJ; Pankratz VS; Mielke MM; Petersen RC; Geda YE
    Neurology; 2015 Mar; 84(9):935-43. PubMed ID: 25653291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuropsychiatric symptoms in at-risk groups for AD dementia and their association with worry and AD biomarkers-results from the DELCODE study.
    Sannemann L; Schild AK; Altenstein S; Bartels C; Brosseron F; Buerger K; Cosma NC; Fliessbach K; Freiesleben SD; Glanz W; Heneka MT; Janowitz D; Kilimann I; Kobeleva X; Laske C; Metzger CD; Munk MHJ; Perneczky R; Peters O; Polcher A; Priller J; Rauchmann B; Rösch C; Rudolph J; Schneider A; Spottke A; Spruth EJ; Teipel S; Vukovich R; Wagner M; Wiltfang J; Wolfsgruber S; Duezel E; Jessen F;
    Alzheimers Res Ther; 2020 Oct; 12(1):131. PubMed ID: 33066827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Longitudinal Assessment of Neuropsychiatric Symptoms in Mild Cognitive Impairment and Alzheimer's Disease and Their Association With White Matter Hyperintensities in the National Alzheimer's Coordinating Center's Uniform Data Set.
    Anor CJ; Dadar M; Collins DL; Tartaglia MC
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2021 Jan; 6(1):70-78. PubMed ID: 32389747
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Occurrence of neuropsychiatric symptoms and psychiatric disorders in mild Alzheimer's disease and mild cognitive impairment subtypes.
    Di Iulio F; Palmer K; Blundo C; Casini AR; Gianni W; Caltagirone C; Spalletta G
    Int Psychogeriatr; 2010 Jun; 22(4):629-40. PubMed ID: 20367890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alzheimer's disease biomarkers as predictors of trajectories of depression and apathy in cognitively normal individuals, mild cognitive impairment, and Alzheimer's disease dementia.
    Banning LCP; Ramakers IHGB; Rosenberg PB; Lyketsos CG; Leoutsakos JS;
    Int J Geriatr Psychiatry; 2021 Jan; 36(1):224-234. PubMed ID: 32869375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of race, baseline cognition, and APOE on the association of affective dysregulation with incident dementia: A longitudinal study of dementia-free older adults.
    Ebrahim IM; Ghahremani M; Camicioli R; Smith EE; Ismail Z
    J Affect Disord; 2023 Jul; 332():9-18. PubMed ID: 36997127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuropsychiatric Symptoms and Risk Factors in Mild Cognitive Impairment: A Cohort Investigation of Elderly Patients.
    Yang AN; Wang XL; Rui HR; Luo H; Pang M; Dou XM
    J Nutr Health Aging; 2020; 24(2):237-241. PubMed ID: 32003417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuropsychiatric symptoms and Apolipoprotein E: Associations with eventual Alzheimer's disease development.
    Burke SL; Maramaldi P; Cadet T; Kukull W
    Arch Gerontol Geriatr; 2016; 65():231-8. PubMed ID: 27111252
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuropsychiatric Symptoms in Mild Cognitive Impairment: A Literature Review.
    Martin E; Velayudhan L
    Dement Geriatr Cogn Disord; 2020; 49(2):146-155. PubMed ID: 32289790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical associations of anosognosia in mild cognitive impairment and Alzheimer's disease.
    Mak E; Chin R; Ng LT; Yeo D; Hameed S
    Int J Geriatr Psychiatry; 2015 Dec; 30(12):1207-14. PubMed ID: 25754519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Depression in mild cognitive impairment is associated with progression to Alzheimer's disease: a longitudinal study.
    Van der Mussele S; Fransen E; Struyfs H; Luyckx J; Mariën P; Saerens J; Somers N; Goeman J; De Deyn PP; Engelborghs S
    J Alzheimers Dis; 2014; 42(4):1239-50. PubMed ID: 25024328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuropsychiatric Symptoms and Functional Connectivity in Mild Cognitive Impairment.
    Munro CE; Donovan NJ; Guercio BJ; Wigman SE; Schultz AP; Amariglio RE; Rentz DM; Johnson KA; Sperling RA; Marshall GA
    J Alzheimers Dis; 2015; 46(3):727-35. PubMed ID: 25854929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuropsychiatric symptoms as a distinguishing factor between memory diagnoses.
    Rouse HJ; Small BJ; Schinka JA; Hazlett AM; Loewenstein DA; Duara R; Potter H
    Int J Geriatr Psychiatry; 2020 Oct; 35(10):1115-1122. PubMed ID: 32391573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progression to Dementia or Reversion to Normal Cognition in Mild Cognitive Impairment as a Function of Late-Onset Neuropsychiatric Symptoms.
    McGirr A; Nathan S; Ghahremani M; Gill S; Smith EE; Ismail Z
    Neurology; 2022 May; 98(21):e2132-e2139. PubMed ID: 35351783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.